Silk, A. W., Silk, A. W., Silk, A. W., Silk, A. W., Curti, B., Bryan, J., . . . McDermott, D. F. (2023). A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationSilk, Ann W., et al. A Phase Ib Study of Interleukin-2 Plus Pembrolizumab for Patients with Advanced Melanoma. Frontiers Media S.A, 2023.
MLA (9th ed.) CitationSilk, Ann W., et al. A Phase Ib Study of Interleukin-2 Plus Pembrolizumab for Patients with Advanced Melanoma. Frontiers Media S.A, 2023.
Warning: These citations may not always be 100% accurate.